| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
61,295 |
54,655 |
$6.13M |
| S9083 |
Global fee urgent care centers |
26,014 |
23,294 |
$3.00M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,360 |
16,301 |
$1.53M |
| 99215 |
Prolong outpt/office vis |
11,733 |
11,078 |
$1.30M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,734 |
10,534 |
$1.00M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,178 |
6,067 |
$648K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,564 |
2,558 |
$245K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,458 |
4,857 |
$128K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21,334 |
20,224 |
$109K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
6,461 |
6,089 |
$106K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17,418 |
10,228 |
$106K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
689 |
680 |
$70K |
| 99205 |
Prolong outpt/office vis |
568 |
566 |
$68K |
| 99201 |
|
296 |
295 |
$30K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
274 |
218 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
714 |
684 |
$3K |
| 87807 |
|
289 |
277 |
$1K |
| 81003 |
|
1,650 |
1,572 |
$973.89 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
686 |
657 |
$366.60 |
| 73610 |
|
59 |
58 |
$312.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
26 |
$304.60 |
| 73630 |
|
41 |
39 |
$180.05 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
241 |
233 |
$70.16 |
| 99000 |
|
3,429 |
3,301 |
$46.00 |
| 73130 |
|
12 |
12 |
$45.00 |
| 73110 |
|
16 |
13 |
$30.00 |
| 73140 |
|
26 |
26 |
$20.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
13 |
13 |
$10.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
31 |
30 |
$3.00 |
| 81002 |
|
16 |
15 |
$0.00 |